Psoriatic arthritis: prospects for the future

Psoriatic arthritis: prospects for the future

Psoriatic arthritis (PsA) is a form of chronic inflammatory arthritis associated with psoriasis and a multitude of other symptoms, most commonly arthritis, dactylitis, enthesitis and axial involvement. PsA is significantly heterogeneous, with a highly variable clinical course of PsA. Patients may ex...

Bibliografski detalji
Glavni autori:	Hackett, S, Ogdie, A, Coates, LC
Format:	Journal article
Jezik:	English
Izdano:	SAGE Publications 2022

Slični predmeti

Psoriatic arthritis: prospects for the future
od: Simon Hackett, i dr.
Izdano: (2022-03-01)

Measuring outcomes in psoriatic arthritis
od: Ogdie, A, i dr.
Izdano: (2020)

Outcome measures in psoriatic arthritis: where next?
od: Hackett, S, i dr.
Izdano: (2022)

Psoriatic arthritis
od: FitzGerald, O, i dr.
Izdano: (2021)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
od: Ogdie, A, i dr.
Izdano: (2023)

Psoriatic arthritis: An up to date overview
od: Simon Hackett, i dr.
Izdano: (2020-01-01)

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores
od: Weinstein, SM, i dr.
Izdano: (2021)

Classification and outcome measures for psoriatic arthritis
od: Leung, Y, i dr.
Izdano: (2018)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
od: Vivekanantham, A, i dr.
Izdano: (2024)

Sex-specific differences in patients with psoriatic arthritis: a systematic review
od: Coates, LC, i dr.
Izdano: (2022)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
od: Soriano, ER, i dr.
Izdano: (2023)

How should we define disease and outcomes in axial psoriatic arthritis?
od: Coates, LC
Izdano: (2021)

Identification of psoriatic arthritis in patients with psoriasis
od: Coates, LC, i dr.
Izdano: (2023)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
od: Ye, W, i dr.
Izdano: (2021)

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate
od: Coates, LC, i dr.
Izdano: (2023)

Obesity and Psoriatic Arthritis: A Narrative Review
od: Anand Kumthekar, i dr.
Izdano: (2020-06-01)

Psoriatic arthritis in developing and resource-poor countries
od: Maharaj, AB, i dr.
Izdano: (2020)

The Multidimensional Health Assessment Questionnaire (MDHAQ) and the Heath Assessment Questionnaire Disability Index (HAQDI): a comparison in patients with psoriatic arthritis
od: Ye, W, i dr.
Izdano: (2020)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
od: Alexis Ogdie, i dr.
Izdano: (2023-05-01)

Residual disease associated with suboptimal treatment response in patients with psoriatic arthritis: a systematic review of real world evidence
od: Coates, LC, i dr.
Izdano: (2022)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
od: Braun, J, i dr.
Izdano: (2023)

The role of ultrasound in psoriatic arthritis — do we need a score?
od: D'Agostino, MA, i dr.
Izdano: (2019)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
od: Ye, W, i dr.
Izdano: (2021)

Sex-specific challenges in patients with psoriatic arthritis (PsA): preliminary results from a systematic literature review (SLR)
od: Coates, LC, i dr.
Izdano: (2021)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
od: Helliwell, PS, i dr.
Izdano: (2022)

The need for clarity on the use of glucocorticoids for people with psoriatic arthritis: a call for consensus
od: Tillett, W, i dr.
Izdano: (2022)

Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis
od: Leung, YY, i dr.
Izdano: (2020)

Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the USA and Europe
od: Ogdie, A, i dr.
Izdano: (2022)

Psoriatic arthritis and the association with cardiometabolic disease: a narrative review
od: Paras Karmacharya, i dr.
Izdano: (2021-03-01)

The State of the Art - Psoriatic Arthritis outcome assessment in clinical trials and daily practice
od: Day, J, i dr.
Izdano: (2022)

Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
od: Mease, PJ, i dr.
Izdano: (2020)

The road to personalised medicine in psoriatic arthritis
od: White, JPE, i dr.
Izdano: (2021)

What should be the primary target of "treat to target" in psoriatic arthritis?
od: Coates, LC, i dr.
Izdano: (2018)

Methotrexate in psoriasis and psoriatic arthritis
od: Coates, L, i dr.
Izdano: (2020)

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies
od: Tillett, W, i dr.
Izdano: (2017)

Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis
od: Pournara, E, i dr.
Izdano: (2021)

Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
od: Philip J. Mease, i dr.
Izdano: (2024-01-01)

Real‐World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
od: Philip J. Mease, i dr.
Izdano: (2023-08-01)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
od: Coates, LC, i dr.
Izdano: (2022)

Longitudinal analysis of the patient pathways to diagnosis of psoriatic arthritis
od: Alexis Ogdie, i dr.
Izdano: (2021-10-01)